08:00       Registration, Partnering Meetings & Networking in the Exhibition Hall

08:30       Welcome & Introduction
                    Johan Rockberg,  Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

08:35       Blood Biomarkers of Alzheimer’s Disease and Dementia Prediction in Older Adults with Complex Clinical Profiles
                     Giulia Grande, MD, PhD in Epidemiology, Karolinska Institutet

09:00       Fluid Biomarkers in Epilepsy
                     Johan Zelano, Professor of Neurology, University of Gothenburg and Sahlgrenska University Hospital

09:25       Enabling Scientific Breakthroughs
                     Jing Dai, Regional Sales Manager, MedChemExpress

09:50       Coffee, Partnering Meetings & Networking in the Exhibition Hall            

10:30       Antibody-Based PET Imaging of Disease Targets in the Brain
                     Dag Sehlin, Professor of Molecular Geriatrics, Uppsala University

10:55       Project AQ280 – A Potential Breakthrough Therapy in Eosinophilic Esophagitis
                     Sarah Fredriksson, CEO, Aqilion

11:20       The Zebrafish: An Animal Model with the Potential to Revolutionize Basic and Pre-Clinical Research
                     Lars Bräutigam, PhD, Head of Zebrafish Core Facility, Karolinska Institutet

11:45       Uncovering Hidden Biology: Your Fastest Path to Your Next Breakthrough

                     Fredrik Barrenäs, Senior researcher in Bioinformatics, Immunology, and AI – CTO and Co-founder, Mavatar

12:10       Lunch, Partnering Meetings & Networking in the Exhibition Hall

13:10       The Future of IP in Biosciences: IP Protection and Ownership in the AI (a)era
                     Ylva Skoglösa, Founder and Partner, aera
                     Aaron J Kraft, U.S. Patent Attorney and U.S. Attorney-at-Law, aera

13:35       Towards Precision Nutrition for Cardiometabolic Health
                     Rikard Landberg, Professor of Food and Health, Head of Division of Food and Nutrition Science, Chalmers University of Technology

14:00       Cardiotoxicity of Anti-HER2 Therapies in Breast Cancer, Current Status and Future Perspectives
                     Andri Papakonstantinou, Chief Consultant Breast, Endocrine Tumors and Sarcoma Oncology Unit, Karolinska University Hospital

14:25       Turning the Tide of Antimicrobial Resistance (AMR)
                     Fredrik Almqvist, Co-founder and CSO, QureTech Bio

14:50       Coffee, Partnering Meetings & Networking in the Exhibition Hall

15:20       The Interplay Between Transcription, Topoisomerases and the Oncogene MYC: A New Twist in Anticancer Treatment
                     Laura Baranello,Principal Researcher – Associate Professor, Department of Cell and Molecular Biology, Karolinska Institutet

15:45       Bioconjugates: Synthetic Stategies, Analytical Workflows, and Key Challenges
                     Jonas Malmström, Principal Research Scientist, Ofichem Uppsala
                     Matthijs Pijnappel, Senior Research Scientist, Ofichem Uppsala

16:10       Revolutionary New Treatment for Diabetes Type 1 and 2
                     Adam Bruce, CEO and Chair, Abarceo Pharma

16:35       Summary & Conclusion
                     Johan Rockberg, Professor in Antibody Technology and Directed Evolution, KTH Royal Institute of Technology

16:40       End of Agenda